Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ)
CNY 5.25
(-2.42%)
CNY 5.25
(-2.42%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 CNY | 86.94% |
| 2022 | -0.07 CNY | 34.9% |
| 2021 | -0.10 CNY | 75.0% |
| 2020 | -0.40 CNY | -110.53% |
| 2019 | -0.19 CNY | -258.33% |
| 2018 | 0.12 CNY | 76.47% |
| 2017 | 0.07 CNY | 655.56% |
| 2016 | 0.01 CNY | -70.0% |
| 2015 | 0.03 CNY | 115.83% |
| 2014 | 0.01 CNY | -84.36% |
| 2013 | 0.09 CNY | 10.3% |
| 2012 | 0.08 CNY | -26.73% |
| 2011 | 0.11 CNY | 64.92% |
| 2010 | 0.07 CNY | -12.7% |
| 2009 | 0.08 CNY | 14.54% |
| 2008 | 0.07 CNY | -15.78% |
| 2007 | 0.08 CNY | 67.8% |
| 2006 | 0.05 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.01 CNY | 230.23% |
| 2024 Q3 | -0.03 CNY | -569.64% |
| 2024 Q1 | -0.00 CNY | -109.95% |
| 2023 Q3 | -0.00 CNY | 99.16% |
| 2023 Q4 | 0.04 CNY | 10900.0% |
| 2023 Q2 | -0.05 CNY | -1305.88% |
| 2023 FY | - CNY | 86.94% |
| 2023 Q1 | -0.00 CNY | 88.55% |
| 2022 Q1 | -0.02 CNY | 79.17% |
| 2022 Q2 | -0.02 CNY | 14.0% |
| 2022 Q3 | 0.01 CNY | 151.63% |
| 2022 Q4 | -0.03 CNY | -367.57% |
| 2022 FY | - CNY | 34.9% |
| 2021 Q4 | -0.12 CNY | -916.95% |
| 2021 FY | - CNY | 75.0% |
| 2021 Q2 | -0.02 CNY | -128.42% |
| 2021 Q3 | -0.01 CNY | 24.36% |
| 2021 Q1 | 0.05 CNY | 115.25% |
| 2020 Q2 | - CNY | 100.0% |
| 2020 Q4 | -0.36 CNY | -3496.23% |
| 2020 Q1 | -0.01 CNY | 96.55% |
| 2020 FY | - CNY | -110.53% |
| 2020 Q3 | 0.01 CNY | 0.0% |
| 2019 Q3 | 0.03 CNY | -32.92% |
| 2019 FY | - CNY | -258.33% |
| 2019 Q1 | 0.03 CNY | 1124.0% |
| 2019 Q2 | 0.04 CNY | 58.98% |
| 2019 Q4 | -0.29 CNY | -1162.27% |
| 2018 FY | - CNY | 76.47% |
| 2018 Q4 | -0.00 CNY | -110.55% |
| 2018 Q3 | 0.02 CNY | -45.39% |
| 2018 Q2 | 0.04 CNY | -22.5% |
| 2018 Q1 | 0.06 CNY | 948.48% |
| 2017 Q1 | 0.03 CNY | 144.98% |
| 2017 Q3 | 0.02 CNY | -6.87% |
| 2017 FY | - CNY | 655.56% |
| 2017 Q4 | -0.01 CNY | -130.41% |
| 2017 Q2 | 0.02 CNY | -13.38% |
| 2016 FY | - CNY | -70.0% |
| 2016 Q1 | 0.02 CNY | 108.7% |
| 2016 Q2 | 0.02 CNY | -32.92% |
| 2016 Q3 | 0.02 CNY | 11.8% |
| 2016 Q4 | -0.06 CNY | -432.22% |
| 2015 Q2 | 0.00 CNY | -57.83% |
| 2015 Q1 | 0.01 CNY | -86.55% |
| 2015 Q3 | 0.00 CNY | 20.0% |
| 2015 FY | - CNY | 115.83% |
| 2015 Q4 | 0.01 CNY | 173.81% |
| 2014 Q3 | 0.01 CNY | 301.82% |
| 2014 Q4 | 0.06 CNY | 455.86% |
| 2014 Q2 | -0.01 CNY | 80.22% |
| 2014 Q1 | -0.03 CNY | -225.23% |
| 2014 FY | - CNY | -84.36% |
| 2013 Q4 | 0.02 CNY | 167.47% |
| 2013 Q3 | 0.01 CNY | -64.83% |
| 2013 Q2 | 0.02 CNY | -29.13% |
| 2013 Q1 | 0.03 CNY | 0.0% |
| 2013 FY | - CNY | 10.3% |
| 2012 FY | - CNY | -26.73% |
| 2012 Q3 | 0.02 CNY | 0.0% |
| 2012 Q2 | - CNY | -100.0% |
| 2012 Q4 | - CNY | -100.0% |
| 2012 Q1 | 0.03 CNY | 0.0% |
| 2011 Q2 | - CNY | -100.0% |
| 2011 FY | - CNY | 64.92% |
| 2011 Q1 | 0.03 CNY | 0.0% |
| 2011 Q4 | - CNY | -100.0% |
| 2011 Q3 | 0.02 CNY | 0.0% |
| 2010 Q1 | 0.02 CNY | 0.0% |
| 2010 Q3 | 0.01 CNY | 0.0% |
| 2010 Q4 | - CNY | -100.0% |
| 2010 FY | - CNY | -12.7% |
| 2010 Q2 | - CNY | -100.0% |
| 2009 FY | - CNY | 14.54% |
| 2009 Q4 | - CNY | -100.0% |
| 2009 Q3 | 0.02 CNY | 0.0% |
| 2009 Q2 | - CNY | -100.0% |
| 2009 Q1 | 0.02 CNY | 0.0% |
| 2008 FY | - CNY | -15.78% |
| 2008 Q4 | - CNY | -100.0% |
| 2008 Q3 | 0.02 CNY | 0.0% |
| 2007 FY | - CNY | 67.8% |
| 2006 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 1.09 CNY | 100.78% |
| Zhejiang Zhenyuan Share Co., Ltd. | 0.24 CNY | 103.542% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | -0.24 CNY | 96.458% |
| Hubei Guangji Pharmaceutical Co., Ltd. | -0.40 CNY | 97.875% |
| Yifan Pharmaceutical Co., Ltd. | -0.45 CNY | 98.111% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 0.07 CNY | 112.574% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 1.69 CNY | 100.503% |
| Boai NKY Medical Holdings Ltd. | 1.02 CNY | 100.833% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 0.59 CNY | 101.441% |